Axsome Therapeutics, Inc. - 10-Q Filing
Axsome Therapeutics reports Q3 2026 financial results including royalty and milestone revenue from Sunosi and Pharmanovia agreements.
Tickers: $AXSM
More Regulatory news
- United KSK Corp - 10-Q Filing
- AMERICAN SHARED HOSPITAL SERVICES - 8-K Filing
- VIVIC CORP. - 10-K Filing
- WOLVERINE WORLD WIDE INC /DE/ - 10-Q Filing
- BlueOne Technologies, Inc. - 10-Q Filing
- Newton Golf Company, Inc. - 10-Q Filing
- XBiotech Inc. - 10-Q Filing
- Cohen & Co Inc. - 10-Q Filing
- UNITED BANCORP INC /OH/ - 10-Q Filing
- PATRIOT GOLD CORP - 10-Q Filing